Slides
Page 1
CentralReach acquisition March 24, 2025
Page 2
CentralReach acquisition Investment highlights Purchase price: $1.65B (net of $200M tax benefit) Expected financial impact: ~$175M revenue (12-months ending Q2’26) ~$75M EBITDA (12-months ending Q2’26) 20%+ organic revenue & EBITDA growth profile Meets all acquisition criteria Adding another maturing leader to portfolio Financed by revolving credit facility Expected to close in April/May 2025 Company overview Leading cloud-native software solution for Applied Behavior Analysis (“ABA”) therapy providers Over 200,000 professionals utilize purpose-built solutions to provide care for individuals with autism spectrum disorder (“ASD”) Comprehensive platform with highly specialized tools: client set-up, practice management, claims processing, care scheduling, clinical data collection, service delivery & AI modules To be reported in Application Software segment Compelling value creation opportunity 2
Page 3
Clear leader in an attractive & durable niche market 3 Persistent care gap - meaningful shortage of care provider supply vs. learner population demand Greater demand for ABA treatment as the standard of care for individuals with ASD Established medical insurance coverage & reimbursement for ABA treatment Market consolidation benefits customer base (“win with the winners”) Strong market tailwinds Helps measure outcomes, ensure compliance, and realize reimbursement Unlocks operational efficiencies, enabling more time to provide quality care Mission critical SaaS solutions with highly tangible ROI Filling care gap drives growth within current installed base Cross-sell of proven AI products with high customer ROI Compelling new logo capture opportunity Adjacent markets - speech/occupational therapies, international expansion, etc. Natural operating leverage as business continues to mature & scale Multiple paths to drive future growth & ability to expand margins